OUTCOMES OF COMBINED TREATMENT IN LOCALLY ADVANCED SOFT TISSUE SARCOMAS
Abstract
Soft tissue sarcomas (STS) constitute 1–2% of all malignant tumors. In 35–45% of patients, the disease is diagnosed in a locally advanced (Stage III) state. At this stage, surgical treatment alone is associated with a high risk (40–60%) of local recurrence, which makes the use of combined treatment methods relevant.
Fields of Study & Subjects
Sarcoma Diagnosis and Treatment
Cancer Research and Treatments
Angiogenesis and VEGF in Cancer
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 8 January 2026